doi: 10.1016/0006-8993(76)90809-x.
Pimozide-induced extinction of intracranial self-stimulation: response patterns rule out motor or performance deficits
- PMID:1252926
- DOI: 10.1016/0006-8993(76)90809-x
Item in Clipboard
Pimozide-induced extinction of intracranial self-stimulation: response patterns rule out motor or performance deficits
G Fouriezos et al. Brain Res..
Display options
Format
Display options
Format
No abstract available
Similar articles
- Neuroleptic attenuation of intracranial self-stimulation: reward or performance deficits?Wise RA.Wise RA.Life Sci. 1978 Feb;22(7):535-42. doi: 10.1016/0024-3205(78)90331-4.Life Sci. 1978.PMID:342858Review.No abstract available.
- Pimozide-induced extinction in rats: stimulus control of responding rules out motor deficit.Franklin KB, McCoy SN.Franklin KB, et al.Pharmacol Biochem Behav. 1979 Jul;11(1):71-5. doi: 10.1016/0091-3057(79)90299-5.Pharmacol Biochem Behav. 1979.PMID:493299
- Pimozide attenuates conditioned taste preferences induced by self-stimulation in rats.Ettenberg A, White N.Ettenberg A, et al.Pharmacol Biochem Behav. 1981 Dec;15(6):915-9. doi: 10.1016/0091-3057(81)90054-x.Pharmacol Biochem Behav. 1981.PMID:7323117
- Non-selective enhancement of locus coeruleus and substantia nigra self-stimulation after termination of chronic dopaminergic receptor blockade with pimozide in rats.Ettenberg A, Wise RA.Ettenberg A, et al.Psychopharmacol Commun. 1976;2(2):117-24.Psychopharmacol Commun. 1976.PMID:981710
- Psychopharmacological aspects of mental depression.Stein L.Stein L.Can Psychiatr Assoc J. 1966;11 Suppl:Suppl:34-49. doi: 10.1177/070674376601101s13.Can Psychiatr Assoc J. 1966.PMID:5328330Review.No abstract available.
Cited by
- Effects of pimozide, across doses and within sessions, on discriminated lever release performance in rats.Skjoldager P, Fowler SC.Skjoldager P, et al.Psychopharmacology (Berl). 1988;96(1):21-8. doi: 10.1007/BF02431528.Psychopharmacology (Berl). 1988.PMID:3147474
- Response decrement patterns after neuroleptic and non-neuroleptic drugs.Sanger DJ.Sanger DJ.Psychopharmacology (Berl). 1986;89(1):98-104. doi: 10.1007/BF00175198.Psychopharmacology (Berl). 1986.PMID:2874584
- Dopamine, behavior, and addiction.Wise RA, Jordan CJ.Wise RA, et al.J Biomed Sci. 2021 Dec 2;28(1):83. doi: 10.1186/s12929-021-00779-7.J Biomed Sci. 2021.PMID:34852810Free PMC article.Review.
- Positive reinforcement mediated by midbrain dopamine neurons requires D1 and D2 receptor activation in the nucleus accumbens.Steinberg EE, Boivin JR, Saunders BT, Witten IB, Deisseroth K, Janak PH.Steinberg EE, et al.PLoS One. 2014 Apr 14;9(4):e94771. doi: 10.1371/journal.pone.0094771. eCollection 2014.PLoS One. 2014.PMID:24733061Free PMC article.
- The dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers.Liggins J, Pihl RO, Benkelfat C, Leyton M.Liggins J, et al.PLoS One. 2012;7(1):e28370. doi: 10.1371/journal.pone.0028370. Epub 2012 Jan 4.PLoS One. 2012.PMID:22238577Free PMC article.Clinical Trial.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources